Catheter-Based Treatment of Cardiovascular Disease
This study offers catheter-based treatment of heart or artery disease. This protocol permits treatment of patients with cardiovascular diseases who may not be eligible to participate in current research protocols. The treatment offered in this protocol is not experimental, but rather standard treatment provided in most large referral hospitals in the United States.
Patients 18 years of age and older who are candidates for catheter-based treatment of obstructive artery disease, including blocked blood flow in a coronary artery (artery to the heart) or in an artery of the arm, leg, brain or kidney may be eligible for this study. Candidates are screened with a general medical evaluation that may include blood tests, magnetic resonance imaging, and monitoring of heart rate and rhythm.
Participants undergo angioplasty or stenting for blockage in an artery to the heart or an artery of the arm, leg, brain or kidney. The procedure uses a balloon-tipped catheter to open the blocked artery and likely requires permanent implantation of a metal tube (stent) to improve blood flow through the vessel. During the procedure, the patient is given a sedative and pain medication, if needed.
|Obstructive Coronary Artery Disease Obstructive Peripheral Artery Disease Structural Heart Disease||Procedure: Percutaneous Transluminal Angioplasty|
|Study Design:||Primary Purpose: Treatment|
|Official Title:||Catheter-Based Treatment of Cardiovascular Disease in Patients|
|Study Start Date:||September 20, 2006|
|Estimated Study Completion Date:||March 3, 2009|
The NHLBI is developing novel minimally invasive catheter-based treatments for cardiovascular disease. These investigational treatments require that physicians, nurses and technical staff maintain and expand their technical skills in the conduct of conventional catheter-based treatments.
This protocol permits treatment of patients with cardiovascular diseases who are not necessarily eligible to participate in existing clinical research protocols, but who are of medical interest for the purpose of training professional staff, or who may be eligible for adjunctive investigational imaging during clinical treatment. Efforts will be made to offer treatment to patients with limited financial resources or with limited access to specialty health care.
This protocol also provides a mechanism to offer catheter-based treatment of cardiovascular disease to patients, so that they may participate in technical development protocols in cardiovascular intervention or in cardiovascular imaging.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00380016
|United States, Maryland|
|National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|